Cargando…
COVID-19 Induced Coagulopathy (CIC): Thrombotic Manifestations of Viral Infection
Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and may result in an overactive coagulative system, thereby resulting in serious cardiovascular consequences in critically affected patients. The respiratory tract is a primary target fo...
Autores principales: | Sharma, Swati, Mishra, Aastha, Ashraf, Zahid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913175/ https://www.ncbi.nlm.nih.gov/pubmed/35280973 http://dx.doi.org/10.1055/s-0042-1744185 |
Ejemplares similares
-
COVID-19 Associated Coagulopathy and Thrombotic Complications
por: Mezalek, Zoubida Tazi, et al.
Publicado: (2020) -
Coagulopathy in COVID-19: Focus on vascular thrombotic events
por: Shi, Wei, et al.
Publicado: (2020) -
The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia
por: Iba, Toshiaki, et al.
Publicado: (2022) -
Understanding Inflammatory Responses in the Manifestation of Prothrombotic Phenotypes
por: Chanchal, Shankar, et al.
Publicado: (2020) -
Haematological manifestations of COVID‐19: From cytopenia to coagulopathy
por: Agbuduwe, Charles, et al.
Publicado: (2020)